Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DAP000099

Drug Information
SynonymsMLS001056714; Stim; NCGC00090699-03; Caffine; Quick Pep; Theophylline, 7-methyl; nchembio774-comp2; 3,7-dihydro-1,3,7-trimethyl-1H-purine; Cafecon; Passauer Brand of Caffeine; Caffeine (USP); AC-12774; BSPBio_001921; Coffeine; DivK1c_000730; NCGC00168808-02; Coffein; Caffedrine Caplets; KBio1_000730; NCGC00015208-02; Caffeine Pure; Bio1_001451; Seid Brand of Caffeine; Theobromine, 1-methyl-; CHEMBL113; C1778_SIAL; Nodaca; Methylxanthine theophylline; SMR000326667; KBio2_001781; CCRIS 1314; nchembio.243-comp7; NINDS_000730; LS-237; Caffeine (natural); Vivarin; NCGC00090699-06; Caffeine solution; DB00201; No-Doz; Republic Drug Brand of Caffeine; Bio-0579; Pierre Fabre Brand of Caffeine; Lopac0_000228; C2042; Refresh'n; 1,3,7-Trimethyl-2,6-dioxopurine; NCGC00015208-14; C6035_SIGMA; Spectrum3_000321; MolPort-000-730-850; Natural Caffeinum; Anhydrous caffeine (TN); 1-methyltheobromine; Caffeine, synthetic; CFF; NCIOpen2_008255; Quick-Pep; C8960_SIAL; DHC Plus; Bio1_000473; Spectrum4_001782; Diurex; caffeine; BIDD:PXR0172; 1l5q; Tri-Aqua; CHEBI:27732; P-A-C Analgesic Tablets; D00528; Methyltheobromine; Coffeinum; A.S.A. and Codeine Compound; 27602_FLUKA; Caffeine [BAN:JAN]; KBio2_004349; 1gfz; Mateina; Coffeinum Purrum; Durvitan; caffenium; PDSP2_001000; EINECS 200-362-1; Thompson Brand 1 of Caffeine; Caffein; Coffeinum N; Probes2_000128; Spectrum_001301; HSDB 36; 07E4FB58-FD79-4175-8E3D-05BF96954522; Midol Maximum Strength; 2a3b; KBioSS_001781; UNII-3G6A5W338E; PDSP2_001219; 71701-02-5; AI3-20154; Propoxyphene Compound-65; Anacin Maximum Strength; Anhydrous caffeine (JP15); BIM-0050216.0001; 95789-13-2; NCGC00090699-04; C7731_SIAL; KBio3_001141; 1l7x; Eldiatric C; component of Cafergot; NCGC00090699-08; Pep-Back; CU-01000012617-3; HMS2091O11; FEMA No. 2224; 7-Methyltheophylline; NCGC00090699-07; Xanthine, 1,3,7-trimethyl; Organex; BIDD:ER0554; cafeine; Compound 65; No Doz; KBioGR_002325; Cafamil; NSC 5036; Hycomine; Theobromine Me; SPECTRUM1500155; NCGC00090699-01; Dasin; Lopac-C-0750; Cafeina; Caffeina [Italian]; Merck dura Brand of Caffeine; Alert-pep; SPBio_001222; NCGC00090699-05; SDCCGMLS-0064595.P002; Thompson Brand 2 of Caffeine; SDCCGMLS-0064595.P001; Thein; IDI1_000730; Coffein [German]; MLS001066409; teina; Enerjets; Koffein; AC1Q3Z23; Caffeine, Monohydrate; TNP00310; Bristol-Myers Squibb Brand of Caffeine; 58-08-2; NCI-C02733; Probes1_000150; Wake-Up; HMS1920I09; D002110; BRD-K02404261-001-03-5; Keep Alert; PDSP1_001016; AKOS000121334; Spectrum5_000423; Propoxyphene Compound 65; Kofein [Czech]; C6035_FLUKA; ACon1_000085; NCGC00015208-04; BRD-K02404261-001-02-7; EU-0100228; MLS001055341; Dexitac; Hycomine Compound; Spectrum2_001261; 1,3,7-Trimethylpurine-2,6-dione; Nodoz Maximum Strength Caplets; Ultra Pep-Back; BRN 0017705; SK 65 Compound; Caffeine, anhydrous; HMS502E12; bmse000206; Cafipel; NCGC00168808-01; SK-65 Compound; Phensal; Miudol; Methyltheobromide; 75035_FLUKA; Tirend; 5-26-13-00558 (Beilstein); Percoffedrinol N; Theine; AC1L1DV2; Monomethyl derivative of Theophylline; Koffein [German]; nchembio.63-comp5; Bio1_000962; ZINC00001084; L000155; C07481; Theophylline Me; BIDD:GT0632; Guaranine; C0750_SIAL; KBio2_006917; MolMap_000054; Kofein; W222402_ALDRICH; CID2519; NCGC00015208-01; I14-4386; Ercatab; Dexitac Stay Alert Stimulant; WLN: T56 BN DN FNVNVJ B1 F1 H1; Caffeina; NCGC00090699-09; MEGxp0_001350; 1-3-7-TRIMETHYLXANTHINE; Caffedrine; STK177283; Berlin-Chemie Brand of Caffeine; GlaxoSmithKline Brand of Caffeine; Anhydrous caffeine; NCGC00090699-02; Percutafeine; Nix Nap; PDSP1_001235; NSC5036; C 0750; 1,3,7-Trimethylxanthine; DHCplus    
Trade NameCafcit    
CompanyBen Venue Laboratories    
IndicationFatigue and orthostatic hypotensionApproved    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Therapeutic ClassAntihypertensive Agents    
CAS NumberCAS 58-08-2
PubChem Compound IDCID 2519.    
PubChem Substance IDSID 9684.    
SuperDrug ATC IDN06BC01;    
SuperDrug CAS ID000058082;    
TargetAdenosine A1 receptorAntagonist[2][3]
Adenosine A1 receptorMultitarget[2][3]
Adenosine A2a receptorAntagonist[2][3]
Adenosine A2a receptorMultitarget[2][3]
Ref 1Fatigue: an overview. Am Fam Physician. 2008 Nov 15;78(10):1173-9. To Reference
Ref 2Caffeine as a psychomotor stimulant: mechanism of action. Cell Mol Life Sci. 2004 Apr;61(7-8):857-72. To Reference
Ref 3Adenosine receptor antagonists intensify the benzodiazepine withdrawal signs in mice. Pharmacol Rep. 2006 Sep-Oct;58(5):643-51. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543